PD-L1 expression is observed in CD68+ and CD11+ cells within TLSs, and the spatial colocalization of CD8+PD1+ with CD11c+PDL1+ cells in TLSs is clinically relevant to the treatment response in NSCLC patients. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.